Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Report: USP Expert Advisory Panel on Pharmacy Compounding Practices

Author(s):  Allen Loyd V Jr

Issue:  Mar/Apr 1999 - Compounding for Men's Health
View All Articles in Issue

Page(s):  126-127

Report: USP Expert Advisory Panel on Pharmacy Compounding Practices Page 1
Report: USP Expert Advisory Panel on Pharmacy Compounding Practices Page 2

Download in electronic PDF format for $75

Abstract:  The work of the United States Pharmacopeial Convention Expert Advisory Panel on Pharmacy Compounding Practices has far-reaching consequences for the practice of pharmacy in the development of standards for compounded medications and the manner of their preparation. This article discusses the panel and the monograph development process and summarizes activities to date.

Related Keywords: product monographs, quality control, sterility requirements, stability, pharmacy practice, Food and Drug Administration (FDA), Pharmacopeial Forum

Related Categories: BUSINESS, LEGAL, UNITED STATES PHARMACOPEIA CONVENTIONS

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Report: USP Expert Advisory Panel on Pharmacy Compounding Practices
Allen Loyd V Jr
Mar/Apr 1999
Pg. 126-127

Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines
Allen Loyd V Jr
Jul/Aug 2016
Pg. 351

View Sample
Applying Quality of Design Concepts to Pharmacy Compounding
Timko Robert J
Nov/Dec 2015
Pg. 453-463

U.S. Food and Drug Administration Inspections: Guide to a Successful Outcome for 503A Sterile Compounding Pharmacies
Yoch Doug
Mar/Apr 2017
Pg. 95-102

PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs
Allen Loyd V Jr
Sep/Oct 2017
Pg. 356

Certification, Accreditation, and Credentialing for 503A Compounding Pharmacies
Pritchett Jon
, McCrory Gary, Kraemer Cheri, Jensen Brenda, Allen Loyd V Jr
Jan/Feb 2018
Pg. 7-16

Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 1
Martin Matt
Sep/Oct 2018
Pg. 401-404

Environmental Sterility-control Practices in Selected Retail Pharmacies in Sri Lanka: A Study in Kandy District
Tennakoon TMIUK
, Thayananthan Anoya
Nov/Dec 2023
Pg. 503-511

Nominations of Difficult to Compound Drugs to the U.S. Food and Drug Administration--Pharmacy Compounding Advisory Committee: Part 1
Allen Loyd V Jr
Sep/Oct 2015
Pg. 389-390

Quality Control: Rapid Sterility Testing for Compounding Pharmacies
Taylor Andrew
Jul/Aug 2020
Pg. 299-303

Quality Control Analytical Methods: A Summarized Discussion of Current Good Manufacturing Practice Regulations
Allen Loyd V Jr
May/Jun 2013
Pg. 210-219

A Primer on USP Chapter 797, "Pharmaceutical Compounding - Sterile Preparations," and USP Process for Drug and Practice Standards
Newton David W
, Trissel Lawrence A
Jul/Aug 2004
Pg. 251-263

PreScription: State or Federal Control of Pharmacy Practice
Allen Loyd V Jr
May/Jun 2007
Pg. 178

Documentation: Records and Reports
Akers Michael J
Sep/Oct 2017
Pg. 373-380

Final Guidance for Pharmacy Compounding of Human Drug Products Under Section 503A
Blankenship Cynthia E
Sep/Oct 2014
Pg. 379-380

U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs
Allen Loyd V Jr
Nov/Dec 2015
Pg. 487-488

FDA-funded Report on Compounded Hormones is Tainted, Analysis Shows
Brunner Scott
May/Jun 2021
Pg. 206-209

U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances
Miller David G
Jul/Aug 2015
Pg. 303-305

PreScription: Compounding Pharmacy Issues for 2017
Allen Loyd V Jr
Jan/Feb 2017
Pg. 4

Establishing and Standardizing Preferred Pharmacy Practices in a Multioffice Infusion Company, Part 1
Chamallas Stanley N
, Sullivan Kathleen
Nov/Dec 2002
Pg. 428-432

Return to Top